Do you know blood samples of patients with hepatocellular carcinoma (HCC) and Hepatitis B, carry an altered version of RASSF1A – a tumor-suppressing gene-which interestingly doesn’t show its presence in healthy people?
This fact, from a new study, could serve as a major tool in spotting liver cancer when it is just in the bud, even. Strangely enough, patients treated for HCC but having high levels of altered gene were found more vulnerable to liver cancer.
Chinese researchers sound plausible when they opine that this finding would pave the way for early detection of HCC, which is the 5th common tumor worldwide and in sub-Saharan Africa and Southeast Asia, is the most common cancer, affecting people especially in their 30s.
Source